Concepedia
Statistics
Publications
32
Citations
2.4K
H-Index
23
Active since
1978
Affiliations
Cytel (United States)(Current)
Chugai Pharma (United States)
University of Alberta
Scripps Clinic
University of Toronto
Thomas Arrhenius is an author at Cytel (United States) specializing in life sciences, immunology, and chemistry.
Publications per year
1978–2007
Malonyl Coenzyme A Decarboxylase Inhibition Protects the Ischemic Heart by Inhibiting Fatty Acid Oxidation and Stimulating Glucose Oxidation
Jason R.B. Dyck, Jie‐Fei Cheng, William C. Stanley et al. · Circulation Research · 2004 · 250 citations
Life Sciences, Biochemistry, Cardiology +16
On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs
Donal M. O’Sullivan, Thomas Arrhenius, John Sidney et al. · The Journal of Immunology · 1991 · 238 citations
Life Sciences, Immunology, Molecular Biology +17
Peptide Stability in Drug Development. II. Effect of Single Amino Acid Substitution and Glycosylation on Peptide Reactivity in Human Serum
Michael F. Powell, Tracy Murray Stewart, László Ötvös et al. · Pharmaceutical Research · 1993 · 183 citations
Life Sciences, Biochemistry, Pharmacology +15
Functional consequences of engagement of the T cell receptor by low affinity ligands
Jeff Alexander, Ken Snoke, J Ruppert et al. · The Journal of Immunology · 1993 · 172 citations
Life Sciences, Immunology, Medicinal Chemistry +17
HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions.
Alessandro Sette, John Sidney, Carla Oseroff et al. · The Journal of Immunology · 1993 · 150 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +17
1–5 of 32